Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Sample management specialists win Queen’s Award for Enterprise

by Medical Finance
in News
Sample management specialists win Queen’s Award for Enterprise
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

From Ziath LtdApr 22 2022Reviewed by Maria Osipova

Ziath Ltd has been awarded with a prestigious Queen’s Award for Enterprise (2022) in the International Trade category. 

Sample management specialists win Queen’s Award for Enterprise

Image Credit: Ziath Ltd

This country is renowned for its entrepreneurial achievements and there is no greater showcase for it than The Queen’s Awards. It is vital we celebrate the success of our businesses and recognise the contributions they make to communities across the country.”

Paul Scully, UK Small Business Minister

We are incredibly pleased and excited to have gained this award, which is personally approved by Her Majesty, Queen Elizabeth the Second. The award recognizes Ziath as a premier exporter of scientific instruments that contribute to Life Science research success worldwide. From our Cambridge, UK, base we export 85% of our production which helps us serve the major drug discovery and life science communities around the world. Our dedicated offices in Maastricht, San Diego, Boston, and Tokyo together with a global Distributor network are poised to support our wonderful customers in forensics, diagnostics, biobanking and pharma who have contributed so greatly to our success. We will cherish this award and strive to produce even more innovative sample management products and software to ensure that Ziath customers always know exactly where their samples are stored.”  

Steve Knight, Commercial Director, Ziath

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Dog brains can detect speech and show different activity patterns to many languages

Study finds more than 1,000 gene-activation differences between female and male mouse brains

by Medical Finance
May 28, 2022
0

Male and female mouse brains differ in important ways, according to a new study led by Stanford Medicine investigators. These...

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth

by Medical Finance
May 28, 2022
0

Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the...

First patient-derived stem cell model developed for studying oculocutaneous albinism

Researchers design a peptide hydrogel for cell spheroids production

by Medical Finance
May 28, 2022
0

This study is led by Prof. Zhimou Yang and Prof. Quan Chen (College of Life Sciences in Nankai University), and...

Leica Microsystems wins distinctive Red Dot design award

Leica Microsystems wins distinctive Red Dot design award

by Medical Finance
May 28, 2022
0

Emspira 3 visual inspection microscope recognized for innovative design The Emspira 3 digital inspection microscope is an all-in-one inspection solution...

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

A new method to produce complex natural products in amoebae

by Medical Finance
May 28, 2022
0

A research team at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI) in...

Scientists unravel how blood cells mount the first line of defense against viruses

Cryo-EM imaging of a key immune protein reveals a previously unrecognized binding site

by Medical Finance
May 28, 2022
0

Imaging at near-atomic resolution of a key immune protein commonly known as STING has revealed a previously unrecognized binding site...

Next Post
Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

A promising approach for COVID-19 prophylaxis

Study: Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children. Image Credit: anon_tae/Shutterstock

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Post COVID-19 Condition in South Africa: 3-month follow-up after hospitalisation with SARS-CoV-2. Image Credit: Alexandros Michailidis/Shutterstock
    Study rules out post-COVID-19 conditions in hospitalized patients in South Africa
  • Hospital 620x480
    New aspergillosis infection model can help better observe the growth of fungus
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply